NephroGenex
http://www.nephrogenex.com/Summary:
NephroGenex is a drug development company focusing on kidney disease. The company is developing Pyridorin™ (pyridoxamine dihydrochloride) as a treatment to slow the progression of diabetic kidney disease. Pyridorin™ has demonstrated a significant treatment effect in slowing the progression of diabetic nephropathy in two Phase IIa clinical trials, and has been awarded Fast Track status by the FDA.
Investors 1
| Date | Name | Website |
| - | Rho Ventur... | rhoventure... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 29.06.2016 | The biotec... | There was a time after the 2... | Financing | John Carro... | endpts.com... |
| 10.07.2007 | NephroGene... | Cary, N.C.-based NephroGenex, ... | - | - | venturebea... |